Table 4 PSA values from included studies, by ethnicity.
PSA values (ng/ml) | ||||||||
|---|---|---|---|---|---|---|---|---|
Study | Age group, years | White | Black | Asian | Hispanic | Other | Outcome summary | |
Mean (SD) | Mean (SD) | Mean (SD) | ||||||
Crawford 2011 [17] | 40+ | 1.02 (0.75) | 1.03 (0.77) | 0.98 (0.68) | No evidence of differences | |||
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||||
DeAntoni 1996 [18] | 40–49 50–59 60–69 70–79 | 0.82 (0.77) 1.2 (1.3) 1.8 (1.9) 2.3 (2.3) | 0.87 (0.92) 1.4 (1.6) 2.0 (2.4) 2.5 (2.7) | 0.85 (0.57) 1.3 (1.6) 1.8 (1.9) 2.3 (2.3) | 0.73 (0.71) 1.3 (1.6) 1.8 (2.1) 2.0 (2.3) | White < Black * (age groups 50–59 and 60–69) | ||
PSA > 4.0 (%) | PSA > 4.0 (%) | PSA>4.0 (%) | ||||||
Espaldon 2014 [19] | 65–69 70–74 75–79 80–84 ≥85 | 5.6 7.0 9.9 13.1 17.0 | 9.8 13.1 17.8 24.0 27.4 | 5.1 9.0 10.6 13.6 18.3 | White/Latino <Black *** (overall, not age-stratified) | |||
Median, 95th | Median, 95th | Median, 95th | ||||||
Gray 2003 [29] | 40–49 50–59 60–69 | 0.7, 2.1 0.9, 2.8 1.4, 4.0 | Maori 0.6, 1.6 0.8, 2.3 1.5, 4.6 | Pacific 0.7, 1.5 0.8, 3.0 1.1, 3.0 | White > Maori* (age-adjusted mean) | |||
PSA > 4.0 (%) | PSA > 4.0 (%) | PSA > 4.0 (%) | ||||||
Gray 2005 [30] | 40–49 50–59 60–69 | 0.4 3.5 11.0 | Maori 0.6 3.2 13.2 | Pacific 1.3 3.7 12.7 | No evidence of differences | |||
Median, 95th | Median, 95th | Median, 95th | ||||||
Lacher 2006 [29] | 40–49 50–59 60–69 ≥70 | 0.70, 2.37 0.90, 3.11 1.10, 4.98 1.70, 8.66 | 0.70, 2.00 0.80, - 1.50, 10.30 - | 0.71, 1.87 0.90, 3.16 1.00, - 1.60, - | White < Black* (95 percentile, age 60–69) | |||
Mean (SE)ǂ | Mean (SE)ǂ | Mean (SE)ǂ | ||||||
Lacher 2015 [21] | 40+ | 1.03 (0.02) | 1.25 (0.07) | 1.11 (0.06) | White < Black* | |||
95th | 95th | 95th | 95th | |||||
Matti 2021 [28] | 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 | 1.60 1.90 2.41 3.19 4.01 4.90 5.87 7.39 | 1.60 1.80 2.29 3.10 3.90 4.81 5.87 7.17 | Maori 1.60 1.90 2.51 3.39 4.48 5.58 7.10 9.39 | Pacific 1.51 1.90 2.61 3.29 4.48 5.99 7.77 10.7 | No evidence of differences | ||
PSA>1.4, n (%) | PSA>1.4, n (%) | |||||||
Rhodes 2012a [22] | N/A | 146 (34.8) | 109 (33.1) | No evidence of differences | ||||
Median (IQR) | Median (IQR) | |||||||
Rhodes 2012b [23] | N/A | 1.2 (0.8–1.8) | 1.0 (0.5–1.7) | White > Black*** (unadjusted for age) | ||||
Median, 90th | Median, 90th | Median, 90th | ||||||
Saraiya 2005 [26] | 40–49 50–59 60–69 70+ | 0.73, 1.53 0.82, 2.42 0.99, 3.25 2.02, 6.30 | 0.65, 1.51 0.90, 3.25 1.59, 5.33 1.84, - | 0.78, 1.55 0.83, - 1.12, 3.19 1.40, - | No evidence of differences | |||
Median, 95th | Median, 95th | |||||||
Sarma 2014 [27] | 40–49 50–59 60–69 70+ | 0.7, 1.8 0.9, 2.9 1.4, 4.6 2.1, 7.1 | 0.8, 2.4 0.8, 3.3 1.1, 6.1 1.4, 5.6 | No evidence of differences | ||||
Median, 95th | Median, 95th | |||||||
Weinrich 1998 [25] | 50 – 59 60 – 69 | 0.8, 2.7 1.0, 4.9 | 0.9, 3.8 1.1, 5.7 | White < Black ** in 50–59 age group (age-stratified mean) | ||||